Featured publications
-
Role and therapeutic potential of vascular stem/progenitor cells in pathological neovascularisation during chronic portal hypertension
Authors:Reference: Gut 2017. -
Therapeutic siRNA targeting endothelial KDR decreases portosystemic collateralization in portal hypertension
Authors:Reference: Scientific Reports 2017. -
Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease
Authors:Reference: Gastroenterology 2016. -
Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats
Authors:Reference: Gut 2015. -
Disruption of negative feedback loop between vasohibin-1 and VEGF decreases portal pressure, angiogenesis and fibrosis in cirrhotic rats
Authors:Reference: Hepatology 2014. -
Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension
Authors:Reference: Journal Of Hepatology 2010. -
Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats
Authors:Reference: Hepatology 2009. -
Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension
Authors:Reference: Journal Of Hepatology 2009. -
Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats
Authors:Reference: Hepatology 2007.
Featured Projects
-
Role and therapeutic potential of CPEB proteins in the transition from cirrhosis to hepatocellular carcinoma
Principal investigator: Jordi BruixFunder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Worldwide Cancer ResearchDuration: 01/01/2016 - 01/01/2019 -
Mecanismos moleculares y celulares implicados en la interacción entre obesidad y enfermedad hepática crónica: papel y potencial terapéutico de la angiogénesis y proteínas CPEB
Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Ministerio de Economía y CompetitividadDuration: 01/01/2015 - 01/01/2018 -
Molecular regulation of the progression from hepatic steatosis to cirrhosis and hepatocellular carcinoma. Role and therapeutic potential of CPEB proteins
Principal investigator: Jordi BruixFunder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Asociación Española Contra el CáncerDuration: 01/01/2015 - 01/01/2020 -
Regulación molecular de la interacción obesidad-enfermedad hepática crónica
Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Ministerio de Economía y CompetitividadDuration: 01/01/2015 - 01/01/2019 -
Regulació de l'angiogènesi en la hipertensió portal i la cirrosi hepàtica. Avaluació de noves estratègies terapèutiques
Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Fundació Marató TV3Duration: 01/01/2009 - 01/01/2011